Senate LDA lobbying filing
PFIZER, INC.
Reported income
$60.0K
Reported expenses
not reported
Tracked program mentions1
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
- Defense Property Accountability System0708047Smatched: “Property|Accountability”matched 2+ title words
Issues related to intellectual property and patent reform, including: S. 150, Affordable Prescriptions for Patients…
Lobbying activities4
Copyright/Patent/TrademarkCPT
Issues related to intellectual property and patent reform, including: S. 150, Affordable Prescriptions for Patients Act; S. 79, Interagency Patent Coordination and Improvement Act; S. 113, Prescription Pricing for the People Act; S. 142, Preserve Access to Affordable Generics and Biosimilars Act; and S. 148, Stop STALLING Act.
PharmacyPHA
Issues related to prescription drug value, including implementation of the Inflation Reduction Act (PL 117-169). Issues related to vaccine development, distribution and injury compensation. Issues related to FDA regulation of pharmaceuticals. Issues related to prescription drug pricing and pharmacy benefit manager business practices, including S. 127, Pharmacy Benefit Manager Transparency Act, S.1339 - Pharmacy Benefit Manager Reform Act, H.R. 2679, the PBM Accountability Act, H.R.4822 - Health Care Price Transparency Act, H.R. 5378 - Lower Costs, More Transparency Act. Issues related to the 340B program, including H.R. 3290, to ensure transparency and oversight of the 340B drug discount program. Pandemic All-Hazards Preparedness Act (PAHPA) reauthorization, including S.2333 - Pandemic and All-Hazards Preparedness and Response Act. H.R.10545, FY25 Continuing Appropriations.
Taxation/Internal Revenue CodeTAX
Issues related to vaccine excise taxes and the Vaccine Injury Compensation Fund.
Trade (domestic/foreign)TRD
Issues related to waiving intellectual property protections for COVID-19 vaccines and theraputics under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement). Issues related to the National Institute of Standards and Technology request for public comment on a Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights.
Lobbyists4
- HAZEN MARSHALL
- HAZEN MARSHALLrevolving door
Policy Director, Senate Majority Leader Mitch McConnell; Staff Director, Senate Budget Committee-Senator Don Nickles; Deputy Chief of Staff/Economist, Office of Assistant Majority Leader-Senator Don Nickles; Legislative Assistant-Senator Don Nickles
- MONICA POPP
- MONICA POPPrevolving door
Chief of Staff/Deputy Chief of Staff, Office of Senate Republican Whip John Cornyn; Professional Staff Member, U.S. House of Representatives-Energy & Commerce Committee; Legislative Assistant, Senator Jim DeMint
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.